The Hypoglycemic Effect of Cyclocarya Paliurus Extract on Hyperglycemic Populations
NCT ID: NCT04184440
Last Updated: 2019-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2020-03-31
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypoglycemic Efficacy of Greenyn Momordica Charantia Extracts in Diabetic Subjects
NCT03151837
Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects
NCT05738655
The Effect of Momordica Charantia Supplementation on Blood Glucose Levels
NCT04090788
Nutraceutical on Hyperglycemia
NCT04107922
Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Hyperglycemia
NCT03258229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
corn starch；capsule，2 g/day，2 times/day；3 months
placebo
The participants are divided randomly into three groups，one of which are asked to take placebo for three months .
Cyclocarya paliurus extract
aqueous extract of Cyclocarya paliurus；capsule，2 g/day，2 times/day；3 months
Cyclocarya paliurus extract
The participants are divided randomly into three groups，one of which are asked to Cyclocarya paliurus extract for three months .
Cyclocarya paliurus compounds
mixed aqueous extract of Cyclocarya paliurus and other traditional Chinese herbal medicines including Astragalus propinquus Schischkin，Dioscorea oppositifolia L.，Dendrobium nobile Lindl.，Salvia miltiorrhiza Bge. and Inulin；capsule，2 g/day，2 times/day；3 months
Cyclocarya paliurus compounds
The participants are divided randomly into three groups，one of which are asked to take Cyclocarya paliurus compounds for three months .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cyclocarya paliurus extract
The participants are divided randomly into three groups，one of which are asked to Cyclocarya paliurus extract for three months .
Cyclocarya paliurus compounds
The participants are divided randomly into three groups，one of which are asked to take Cyclocarya paliurus compounds for three months .
placebo
The participants are divided randomly into three groups，one of which are asked to take placebo for three months .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age:20-65 years;
* BMI :20-35kg/m2.
Exclusion Criteria
* type 2 diabetic patients with insulin treatment；
* pregnant or lactating women；
* adverse effect on intervention；
* acute or chronic inflammatory conditions;
* severe hepatic,kidney or other complications;
* other situations ineligible to intervention.
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Huazhong University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Liegang Liu
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shiyan Taihe Hospital
Shiyan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QQLY2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.